Who owns HEPION PHARMACEUTICALS INC COM NEW?
- Ticker: HEPA
- CUSIP Number: 426897302
Tip: Access positions for across all investors
Analyze quarterly positions in Hepion Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Hepion Pharmaceuticals stock
Who bought or sold HEPION PHARMACEUTICALS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 160k | $520k | -3% | Dec 2023 |
|
| Virtu Financial | 13k | $41k | 100% | Dec 2023 |
|
| Pnc Financial Services | 2.9k | $9.3k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 1.1k | $3.6k | 21960% | Dec 2023 |
|
| AdvisorNet Financial | 176.00 | $437.993600 | 100% | Mar 2024 |
|
| Bank of America Corporation | 114.00 | $342.000000 | 11300% | Dec 2023 |
|
| Advisor Group Holdings | 114.00 | $368.995200 | -97% | Dec 2023 |
|
| Wells Fargo & Company | 33.00 | $106.999200 | 18% | Dec 2023 |
|
| Royal Bank of Canada | 20.00 | $0 | -76% | Dec 2023 |
|
| Barclays | 16.00 | $0 | 0% | Dec 2023 |
|
| UBS Group | 2.00 | $6.000000 | 0% | Dec 2023 |
|
| Benjamin F. Edwards & Company | 1.00 | $0 | 0% | Dec 2023 |
|
| Signature | 1.00 | $3.000000 | 0% | Dec 2023 |
|
| Hanson McClain Advisors | 1.00 | $3.000000 | 0% | Mar 2024 |
|
| Global Retirement Partners | 1.00 | $2.000000 | 0% | Mar 2024 |
|
| Harbor Investment Advisory | 1.00 | $2.000000 | 0% | Mar 2024 |
|
Who sold out of Hepion Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Octagon Capital Advisors | Sep 2023 | 68k | $337k |